Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

J&J Says Duragesic Pediatric Exclusivity Is Unrelated To 30-Month Stay

Apr 12 2004

• By The Pink Sheet

Related Content

Mylan Loses Duragesic Case; Generic Launch Timing Dispute Moves To FDA

Apr 05 2004

Mutual’s Accupril Declaratory Judgment Case Versus Pfizer Thrown Out

Apr 05 2004

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window